

| Dosage | Package | Price per Dose | Price | |
|---|---|---|---|---|
| 60mg | 56 pill | AUD32.67 | AUD2,287.37 AUD1,829.89 Best Price Popular | |
| 60mg | 28 pill | AUD38.72 | AUD1,355.37 AUD1,084.30 |
Daclatasvir is a medication used primarily in the treatment of hepatitis C virus (HCV) infection. It belongs to a class of drugs known as direct-acting antivirals (DAAs), which target specific components of the hepatitis C virus to inhibit its replication. By blocking the NS5A protein, Daclatasvir effectively reduces the amount of virus in the body, helping to clear the infection over time. This medication has gained prominence due to its high efficacy, favorable safety profile, and ease of use in combination therapies.
Many patients have reported positive outcomes with Daclatasvir, especially when combined with other antiviral agents like sofosbuvir. The medication's ability to achieve sustained virologic response (SVR) β which indicates a cure β makes it a valuable option for both limited and complex cases of hepatitis C. Its effectiveness is not limited to specific genotypes, making it versatile for various strains of the virus. Additionally, Daclatasvir's oral administration means no injections are needed, simplifying treatment and improving patient compliance.
Daclatasvir is usually prescribed as a once-daily tablet. The typical dosage depends on the patient's specific condition, genotype of hepatitis C, and whether it is used in combination with other medications. It is important for patients to follow their healthcare provider's instructions closely. In most cases, treatment duration varies from 8 to 24 weeks. Consistency in taking the medication is key to achieving optimal results and minimizing the risk of resistance development.
While Daclatasvir is generally well-tolerated, some individuals may experience side effects. Common adverse reactions include fatigue, headache, nausea, and insomnia. Serious side effects are rare but can occur, such as liver-related issues or allergic reactions. It is crucial for patients to report any unusual symptoms to their healthcare professional promptly. Regular monitoring during treatment helps ensure safety and effectiveness.
Before starting Daclatasvir, it is important to disclose all medical conditions and current medications to your healthcare provider. The medication can interact with certain drugs, including some antidepressants, anticonvulsants, and statins. Caution should be exercised especially in patients with severe liver impairment or other underlying health issues. Pregnant or breastfeeding women should consult their doctor, as safety during pregnancy has not been fully established.
Overall, Daclatasvir is a highly effective and convenient option for treating hepatitis C. Its ability to work against various HCV genotypes and its favorable safety profile make it a preferred choice for many patients. When used as part of an appropriate treatment regimen and under medical supervision, it offers new hope for those seeking cure from hepatitis C infection. Proper adherence and regular medical check-ups are essential to maximize the drugβs benefits and ensure a safe treatment process.
14β21 days. Free from AUD288.80 .
5β9 days. AUD43.32
β10% when paying with cryptocurrency.
β10% on all repeat orders.
All orders are packed in neutral, unbranded boxes with no product name on the outside.